Latest filing published 14 Jul 2026 for EyePoint, Inc., €104k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Jay S. Duker across 2 companies, led by EyePoint, Inc. and Sesen Bio, Inc. We count 20 filings; the first trade dates from 9 February 2022 and the latest from 10 July 2026.
On the market, this insider has only ever bought: 1 purchase, €17k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants and 12 option exercises. In 2026 alone, the filings show 1 purchase and no sales.
The latest filing, published on 14 July 2026, reports an option exercise in EyePoint, Inc. The last insider purchase was made public on 16 March 2026, 216 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations